Exelixis (EXEL) Short-term Investments (2010 - 2026)

Exelixis' (EXEL) quarterly Short-term Investments came in at $551.1 million in Q2 2026, down 34.98% year-on-year from $847.6 million in Q2 2025, and down 4.43% quarter-over-quarter from $576.6 million in Q1 2026.

Exelixis (EXEL) Short-term Investments (2010 - 2026) Analysis & Trends

Exelixis' Short-term Investments history runs 17 years deep, the most recent figure standing at $551.1 million for Q2 2026.

  • On a quarterly basis, Short-term Investments fell 34.98% year-over-year to $551.1 million in Q2 2026; TTM through Apr 2026 was $551.1 million, a 34.98% decrease from a year earlier, with the FY2026 full-year figure at $576.6 million, down 35.5% from the prior year.
  • Short-term Investments declined to $551.1 million in Q2 2026 per EXEL's latest filing, from $576.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $930.8 million in Q3 2024 and bottomed at $551.1 million in Q2 2026.
  • The 5-year median for Short-term Investments is $802.3 million (2023), against an average of $764.3 million.
  • Across the five-year window, Short-term Investments jumped 31.74% in 2024 and slumped 35.5% in 2026, its largest moves.
  • Year by year, Short-term Investments stood at $807.3 million in 2022, then slipped by 9.29% to $732.3 million in 2023, then increased by 27.11% to $930.8 million in 2024, then tumbled by 34.23% to $612.2 million in 2025, then decreased by 9.99% to $551.1 million in 2026.
  • Per Business Quant, the three latest EXEL Short-term Investments figures stand at $551.1 million (Q2 2026), $576.6 million (Q1 2026), and $612.2 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 551.06 Mn
Jan 2, 2026 576.60 Mn
Oct 3, 2025 612.24 Mn
Jul 4, 2025 626.67 Mn
Apr 4, 2025 847.56 Mn
Jan 3, 2025 893.90 Mn
Sep 27, 2024 930.82 Mn
Jun 28, 2024 803.54 Mn
Mar 29, 2024 703.70 Mn
Dec 29, 2023 732.31 Mn
Sep 29, 2023 706.53 Mn
Jun 30, 2023 802.34 Mn
Mar 31, 2023 772.54 Mn
Dec 30, 2022 807.27 Mn
Sep 30, 2022 871.71 Mn
Jul 1, 2022 907.94 Mn
Apr 1, 2022 847.06 Mn
Dec 31, 2021 819.91 Mn
Oct 1, 2021 835.41 Mn
Jul 2, 2021 854.17 Mn